Wednesday, December 27, 2023
November 13 - 17, 2020; Virtual
AHA 2020
Resuscitation More Likely With Faster Time to Head-Up CPR
AHA 2020
'Dramatic' Inflammation Reduction After OHCA With Tocilizumab
AHA 2020
Finerenone's Heart Benefits Hold in T2D Without CVD: FIDELIO-DKD
AHA 2020
'Healing' Stent on Par With Durable Polymer Stents: PIONEER III
AHA 2020
Potential New Option: 1-Month DAPT Post DES, Then Aspirin Alone
AHA 2020
Chili Pepper Consumption Linked to Better Midlife Survival
AHA 2020
Many Patients With Type 2 MI Don't Get Cardiologist Evaluation
AHA 2020
Remote, Non-Physician-Led Care Cuts LDL, BP in High-Risk Patients
AHA 2020
Marijuana Use Tied to Repeat MI, Stroke After PCI
AHA 2020
COVID-19 Outcomes Tied to Hospital, Not Just Race
AHA 2020
Stenotic Lesion Outcomes Better if FFR Guides PCI
AHA 2020
RAPID-CTCA: No Gains from CTA in Mid- to High-Risk Suspected ACS
AHA 2020
SGLT1/2 Inhibitor Shows 'Spectacular' Safety, Efficacy in T2D
AHA 2020
Do You Think Fish Oil Has Cardiovascular Benefits?
AHA 2020
Survival Gain Signal After AF Screening With Patch ECG Monitor
AHA 2020
Statins Beneficial in Elderly, Guidelines Should Be Strengthened
AHA 2020
No Extra Cardiopulmonary Event Reduction With High-Dose Flu Vac
AHA 2020
RHAPSODY: Rilonacept Resolves, Prevents Pericarditis Recurrence
AHA 2020
New-Onset AF Common But Unrecognized Early After Cardiac Surgery
AHA 2020
First-Line Ablation Bests Drugs for AFib in Two RCTs
AHA 2020
VTEs Tied to Immune Checkpoint Inhibitor Cancer Treatment
AHA 2020
Target Ticagrelor to Minor Stroke, TIA Patients With AS
AHA 2020
Cardiac Arrest in COVID-19 Pandemic: 'Survival is Possible'
AHA 2020
Chronic Inflammatory Diseases Vary Widely in CHD Risk
AHA 2020
Evinacumab, Novel Lipid-Lowerer, Extends Promise in Phase 2 Results
AHA 2020
OMEMI: No Secondary Prevention Benefit With Omega-3s in Elderly
AHA 2020
SAMSON Pins Most Muscle Pain With Statins on the Nocebo Effect
AHA 2020
STRENGTH Trial Questions CV Benefit of High-Dose Omega-3s
AHA 2020
Empagliflozin Favorably Reshaped LVs in HFrEF Patients
AHA 2020
RIVER: Rivaroxaban Rivals Warfarin in AF, Mitral Bioprosthesis
AHA 2020
Clopidogrel Bests Ticagrelor for Elective PCI
AHA 2020
Combined OCT, Cardiac MRI Unravels Root Cause in Most MINOCA
AHA 2020
TIPS-3: Polypill Provides Meaningful Primary CV Prevention
AHA 2020
GALACTIC-HF: New 'Myotropic' Class Has Modest HFrEF Benefit
AHA 2020
Omega-3, Vit-D Both Fail at AF Primary Prevention in VITAL-Rhythm
AHA 2020
SCAPIS: Simple Questionnaire Can Identify Silent Atherosclerosis
AHA 2020
Don't Miss Cardiovascular Risk Factors in Transgender Patients
AHA 2020
Intravenous Iron Reduces HF Readmissions: AFFIRM-AHF
AHA 2020
Virtual AHA 2020 May Influence Template for Future AHA Sessions
© WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
When the Patient Is the Best Practice Alert: EPIC-HF
No Obstruction Shouldn't Mean No Diagnosis: HARP-MINOCA
Heart Failure Highlights From AHA 2020
The Duty to Inform: Be Galileo on COVID-19
Fish Oils and CV Prevention -- Now What?
SCORED and FIDELIO-DKD: Time for Cardiologists to Help, Not Hurt, the Kidney
SAMSON Trial Makes Its Case to Cut Statin Side Effects
EARLY-AF and STOP AF Put Electrophysiology at a Crossroads
SAMSON Answers the Statin Side Effect Question
Mandrola Previews AHA 2020
